Skip to main content

Animations

We are charting the path to a future free from Parkinson’s. Your support will get us there.

Alleyn Plowright, PhD

Chief Scientific Officer at Pangea Botanica Ltd
Location: London United Kingdom

Associated Grants

  • Development of OT-1xx2, a Novel Small Molecule TrkB Activator, for the Treatment of Parkinson’s Disease

    2025


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.